Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis
- 31 July 1995
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 17 (7) , 597-603
- https://doi.org/10.1016/0192-0561(95)00057-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis — Suppressive effect of TA-383 on interleukin 6 productionInternational Journal of Immunopharmacology, 1993
- FLUCTUATION OF INTERLEUKIN-1 AND -6 ACTIVITY IN BONE MARROW SERUM IN COLLAGEN-INDUCED ARTHRITIS IN RATS Biomedical Research, 1992
- Immunopharmacological studies on a new antirheumatic drug, TA-383The Japanese Journal of Pharmacology, 1992
- Histopathological Study of Arthritic Lesions Induced by Immunization with Type II Collagen in DBA/1J MouseExperimental Animals, 1990
- Anti-arthritic and immunoregulatory effects of TI-31 on collagen-induced arthritis.The Japanese Journal of Pharmacology, 1987
- Evaluation of the effects of various anti-arthritic drugs on type II collagen-induced mouse arthritis modelImmunopharmacology, 1985
- The Role of Collagen Autoimmunity in Animal Models and Human Diseases.Journal of Investigative Dermatology, 1982
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980